Results 31 to 40 of about 10,171 (92)

Mutation of rearranged during transfection (RET) is associated with enhanced tumor immunogenicity and favorable outcomes in pan-cancer immunotherapy. [PDF]

Oncologist
Cai J, Huang Z, Li Y, Zhou J, Xu Y, Cai M, Zhao H, Zhao B.   +7 more
europepmc   +1 more source

<i>RET</i> fusion partners dictate oncogenic potential in undifferentiated spindle cell sarcomas. [PDF]

Cancer Biol Ther
Gui Q, Zhang Y, Yang M, Liang R, Huang M, Yang X, Chen N, Chen X, Wu M, Chen H, Meng L, Xiao S, Tao M.   +12 more
europepmc   +1 more source

Hepatocyte BPGM Induces RET Lactylation and Macrophage Reprogramming to Promote Tumorigenesis in Hepatocellular Carcinoma. [PDF]

Adv Sci (Weinh)
Zhang J, Shi L, Lin L, Zhang Y, Zhang M, Wu L, Xia Y, Zhang Y, Han P, Zhuang L, Shi L.   +10 more
europepmc   +1 more source

Medullary thyroid carcinoma exclusively associated with a homozygous RET V778I pathogenic variant: a case report with review of literature. [PDF]

Endocr J
Kihara M, Miyauchi A, Akamizu T.
europepmc   +1 more source

Combination of Selpercatinib and Trametinib Overcomes Resistance to RET Inhibitors in RET-Mutant Medullary Thyroid Carcinoma. [PDF]

JCO Precis Oncol
Milewski D, Fallatah A, Groff M, Rahmy A, Khan SR, Okafor C, Glassberg B, Chou HC, Heselmeyer-Haddad K, Wangsa D, Wangsa D, Kim Y, Isanogle K, Song Y, Zhang X, Thomas C, Difilippantonio S, Park JI, Wei JS, Hawley RG, Glod J, Khan J.   +21 more
europepmc   +1 more source

Clinical actionability of molecular testing in advanced thyroid cancer: a real-world cohort study. [PDF]

Eur Thyroid J
Changoer P, van Houten P, Ceruti D, van Engen-van Grunsven I, Walraven JEW, Ottevanger PB, Jaeger M, Netea-Maier RT.   +7 more
europepmc   +1 more source

In Silico Studies of Potent Tyrosine Kinase Inhibitors: Molecular Docking and Pharmacophore Modeling Approaches. [PDF]

Molecules
Mavridis E, Pontiki E, Hadjipavlou-Litina D.   +2 more
europepmc   +1 more source

Dual targeting of RET and SRC synergizes in RET fusion-positive cancer cells. [PDF]

Mol Oncol
Son J, Remsing Rix LL, Fang B, Welsh EA, Bremer NV, Foglizzo V, Roa P, Sigcha-Coello N, Liao Y, Haura EB, Drilon A, Koomen JM, Cocco E, Rix U.   +13 more
europepmc   +1 more source

RET receptor tyrosine kinase architecture, assemblies, and activation. [PDF]

Endocr Relat Cancer
Zol-Hanlon M, McDonald NQ.
europepmc   +1 more source

Precision management of medullary thyroid carcinoma: a dynamic framework integrating biomarkers, genotyping, and risk stratification. [PDF]

Front Endocrinol (Lausanne)
Jia C, Guo S, Wu K, Wang Y, Yang S, Wang L, Chen T, Meng X.   +7 more
europepmc   +1 more source